Literature DB >> 30185465

TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.

Youngdae Gwon1, Tae-In Kam1,2, Seo-Hyun Kim1, Sungmin Song1, Hyejin Park1,2, Bitna Lim1, Haneul Lee1, Weontae Lee3, Dong-Gyu Jo4, Yong-Keun Jung5.   

Abstract

Emerging evidences suggest that intraneuronal Aβ correlates with the onset of Alzheimer's disease (AD) and highly contributes to neurodegeneration. However, critical mediator responsible for Aβ uptake in AD pathology needs to be clarified. Here, we report that FcγRIIb2, a variant of Fcγ-receptor IIb (FcγRIIb), functions in neuronal uptake of pathogenic Aβ. Cellular accumulation of oligomeric Aβ1-42, not monomeric Aβ1-42 or oligomeric Aβ1-40, was blocked by Fcgr2b knock-out in neurons and partially in astrocytes. Aβ1-42 internalization was FcγRIIb2 di-leucine motif-dependent and attenuated by TOM1, a FcγRIIb2-binding protein that repressed the receptor recycling. TOM1 expression was downregulated in the hippocampus of male 3xTg-AD mice and AD patients, and regulated by miR-126-3p in neuronal cells after exposure to Aβ1-42 In addition, memory impairments in male 3xTg-AD mice were rescued by the lentiviral administration of TOM1 gene. Augmented Aβ uptake into lysosome caused its accumulation in cytoplasm and mitochondria. Moreover, neuronal accumulation of Aβ in both sexes of 3xTg-AD mice and memory deficits in male 3xTg-AD mice were ameliorated by forebrain-specific expression of Aβ-uptake-defective Fcgr2b mutant. Our findings suggest that FcγRIIb2 is essential for neuropathic uptake of Aβ in AD.SIGNIFICANCE STATEMENT Accumulating evidences suggest that intraneuronal Aβ is found in the early step of AD brain and is implicated in the pathogenesis of AD. However, the critical mediator involved in these processes is uncertain. Here, we describe that the FcγRIIb2 variant is responsible for both neuronal uptake and intraneuronal distribution of pathogenic Aβ linked to memory deficits in AD mice, showing a pathologic significance of the internalized Aβ. Further, Aβ internalization is attenuated by TOM1, a novel FcγRIIb2-binding protein. Together, we provide a molecular mechanism responsible for neuronal uptake of pathogenic Aβ found in AD.
Copyright © 2018 the authors 0270-6474/18/389001-18$15.00/0.

Entities:  

Keywords:  Alzheimer's disease; Amyloid beta (Aβ); Fcγ-receptor IIb; Intraneuronal Aβ; TOM1; miR-126

Mesh:

Substances:

Year:  2018        PMID: 30185465      PMCID: PMC6705977          DOI: 10.1523/JNEUROSCI.1996-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  Role of RAGE in Alzheimer's Disease.

Authors:  Zhiyou Cai; Nannuan Liu; Chuanling Wang; Biyong Qin; Yingjun Zhou; Ming Xiao; Liying Chang; Liang-Jun Yan; Bin Zhao
Journal:  Cell Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.046

2.  AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited.

Authors:  Oliver Wirths; Annika Dins; Thomas A Bayer
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Inhibition of Fcgamma receptor-mediated phagocytosis by a nonphagocytic Fcgamma receptor.

Authors:  S Hunter; Z K Indik; M K Kim; M D Cauley; J G Park; A D Schreiber
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

4.  Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.

Authors:  Joseph F Poduslo; Kyle G Howell; Nicole C Olson; Marina Ramirez-Alvarado; Karunya K Kandimalla
Journal:  Biochemistry       Date:  2012-05-07       Impact factor: 3.162

5.  Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.

Authors:  Ralf P Friedrich; Katharina Tepper; Raik Rönicke; Malle Soom; Martin Westermann; Klaus Reymann; Christoph Kaether; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

6.  Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes.

Authors:  Javier Pacheco-Quinto; Elizabeth A Eckman
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

7.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Authors:  Fiona Pickford; Eliezer Masliah; Markus Britschgi; Kurt Lucin; Ramya Narasimhan; Philipp A Jaeger; Scott Small; Brian Spencer; Edward Rockenstein; Beth Levine; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  Neuronal clearance of amyloid-β by endocytic receptor LRP1.

Authors:  Takahisa Kanekiyo; John R Cirrito; Chia-Chen Liu; Mitsuru Shinohara; Jie Li; Dorothy R Schuler; Motoko Shinohara; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2013-12-04       Impact factor: 6.167

9.  Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.

Authors:  Martina Zandl-Lang; Elham Fanaee-Danesh; Yidan Sun; Nicole M Albrecher; Chaitanya Chakravarthi Gali; Igor Čančar; Alexandra Kober; Carmen Tam-Amersdorfer; Anika Stracke; Steffen M Storck; Ahmed Saeed; Jasminka Stefulj; Claus U Pietrzik; Mark R Wilson; Ingemar Björkhem; Ute Panzenboeck
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-09-20       Impact factor: 5.228

10.  Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes.

Authors:  Karine Dementhon; Sofiane El-Kirat-Chatel; Thierry Noël
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more
  12 in total

1.  Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.

Authors:  Phoebe P Chum; Md A Hakim; Erik J Behringer
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane.

Authors:  Jing-Ming Shi; Li Zhu; Xi Lan; Duan-Wei Zhao; Yong-Jun He; Zheng-Qi Sun; Di Wu; Hai-Yun Li
Journal:  Biophys J       Date:  2020-08-15       Impact factor: 4.033

3.  Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Paul J Nietert; Lisa L Barnes; David A Bennett
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Francesc E Borràs; Katrin Beyer; Ana Gámez-Valero; Jaume Campdelacreu; Dolores Vilas; Lourdes Ispierto; Ramón Reñé; Ramiro Álvarez; M Pilar Armengol
Journal:  Transl Neurodegener       Date:  2019-10-03       Impact factor: 8.014

5.  Cardioprotective role of APIP in myocardial infarction through ADORA2B.

Authors:  Bitna Lim; Kwangmin Jung; Youngdae Gwon; Jae Gyun Oh; Jae-Il Roh; Se-Hoon Hong; Changwon Kho; Woo-Jin Park; Han-Woong Lee; Jang-Whan Bae; Yong-Keun Jung
Journal:  Cell Death Dis       Date:  2019-07-01       Impact factor: 8.469

6.  Amyloid-beta impairs TOM1-mediated IL-1R1 signaling.

Authors:  Alessandra Cadete Martini; Angela Gomez-Arboledas; Stefania Forner; Carlos J Rodriguez-Ortiz; Amanda McQuade; Emma Danhash; Jimmy Phan; Dominic Javonillo; Jordan-Vu Ha; Melanie Tram; Laura Trujillo-Estrada; Celia da Cunha; Rahasson R Ager; Jose C Davila; Masashi Kitazawa; Mathew Blurton-Jones; Antonia Gutierrez; David Baglietto-Vargas; Rodrigo Medeiros; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

Review 7.  Protein Trafficking or Cell Signaling: A Dilemma for the Adaptor Protein TOM1.

Authors:  Tiffany G Roach; Heljä K M Lång; Wen Xiong; Samppa J Ryhänen; Daniel G S Capelluto
Journal:  Front Cell Dev Biol       Date:  2021-02-26

8.  Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis.

Authors:  Quanbao Wang; Xiumin Ge; Jie Zhang; Licheng Chen
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

9.  Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer's disease.

Authors:  Alessandra C Martini; David Baglietto-Vargas; Rodrigo Medeiros; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-11       Impact factor: 11.205

10.  Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer's disease.

Authors:  Andrea Saul Costa; Simone Agostini; Franca Rosa Guerini; Roberta Mancuso; Mario Clerici; Janardan P Pandey
Journal:  J Transl Med       Date:  2020-08-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.